I was honored to take the stage at the National Medical Research Council’s Awards Ceremony and Research Symposium in Singapore recently to speak about ongoing challenges in behavioral health, and the momentum we have in the market to address these challenges.
As a mental health clinician and researcher, I have seen firsthand how our understanding of the role that biological and socioenvironmental factors play in mental health has evolved over time. For many years, the debate over nature vs. nurture dominated discussions in the field, but more recent models have focused on the interaction between genes and the environment, such as the diathesis stress model.
I recently led a team of researchers in a large-scale observational study, which was accepted and published by The Lancet Psychiatry. To our knowledge, our study was the first to study the impact of early clinical trajectory across multiple psychiatric diagnoses.
I recently had the pleasure of joining Real-World Wednesday, a conversation hosted weekly on Clubhouse covering various topics about real-world data. First off, I’d like to thank the hosts of the RWD-RWE Club, Matt Veatch and Aaron Kamauu, for the invitation and the engaging discussion.
Today, Digital Health New York (DHNY) released its Q1 Healthcare Innovation Report, of which we were honored to be a part.
At Holmusk, our vision is to provide fit-for-purpose real-world data that fuel research and innovation in behavioral health. With tons of data captured each day as patients move through healthcare systems—much of it in unstructured data fields—a lot goes on behind the scenes, as we ensure that this information is available and usable for research. Below, you’ll find a quick overview on the types of data that are included in the NeuroBlu Database—as well as the process data go through to ensure they are fit-for-purpose.
With so many types of real-world data available, it can be difficult to select the source that will meet your needs—that is, the data that will help you accurately and efficiently answer your research questions.
This week, we shared the exciting and humbling news that we’ve been named as part of Digital Health New York’s New York Digital Health 100 list, a recognition that highlights the most exciting and innovative digital health startups in the New York region. Co-Founder and CEO of Digital Health New York, Bunny Ellerin, describes the list as “an incredibly diverse, innovative and forward-thinking set of companies and leaders that are making an impact on the future of healthcare.”
Earlier this month, the Substance Abuse and Mental Health Services Administration (SAMHSA) released its annual National Survey on Drug Use and Health (NSDUH), which examined substance use and mental health data from 2021. Although the survey has been administered since 1971, SAMHSA called this year’s “the most comprehensive report on substance use and mental health indicators” that the organization has released to date.
Over seven years ago, I founded Holmusk with the vision that advances in technology and data science could be harnessed to improve health care. Over the company’s lifespan, the vision has crystallized, and we decided to focus first on an area of dire need—behavioral health. We have made great advancements in this space, many of which would not have been realized without the creation and nurturing of fruitful and supportive partnerships.
